Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data

The Health for Hungary (H4H) study collects blood samples and corresponding health data to investigate healthy aging and health-to-disease transitions in middle-aged and elderly participants. Indications Studied: Apparently healthy, symptom-free participants are enrolled and followed up to study the onset of new-onset diseases with special emphasis on non-communicable diseases (NCDs). Study Design: Single-country, multicenter, prospective, longitudinal survey. Objectives: The study aims to establish reference ranges of blood parameters using routine clinical blood tests and high-information-content methods, including proteomics, metabolomics and the so-called infrared molecular fingerprinting. The study also aims to identify novel biomarkers of major non-communicable diseases, including atherosclerotic cardiovascular disease, cancer, diabetes and chronic respiratory disease.

NCT Number	NCT07743021
Lead Sponsor	Center for Molecular Fingerprinting Research Nonprofit LLC Collaborators: Szeged University, Ludwig-Maximilians - University of Munich, Max Planck Institute of Biochemistry, Technical University of Munich, Helmholtz Zentrum München
Conditions	Non-communicable Diseases (NCD), Neoplams, Cancer, Lung Cancer (NSCLC), Cardiovascular Diseases (CVD), Atherosclerotic Cardiovascular Disease (ASCVD), Peripheral Artery Disease (PAD), Coronary Artery Disease (CAD) +6 more
Enrollment	15,000 participants
Start Date	2021-07-27
Primary Completion	2030-12-31 (estimated)
Study Completion	2030-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-03